Tectonic Therapeutic | AVRO - Interest Expense On Debt


Tectonic Therapeutic reported $277M in Interest Expense on Debt for its fiscal quarter ending in September of 2025.





Interest Expense On Debt Change Date
Akebia Therapeutics 364.15M 18.56M Sep/2025
Alnylam Pharmaceuticals USD 129.34M 84.94M Dec/2025
Celltrion KRW 19B 1.96B Jun/2025
Cspc Pharmaceutical CNY 10.19M 4.73M Sep/2025
Deva Holding AS TRY 272.53M 69.04M Sep/2023
Dianthus Therapeutics USD 4.44M 263K Sep/2024
Divis Laboratories Ltd INR 60M 30M Dec/2025
Gilead Sciences USD 255M 1000K Dec/2025
Ionis Pharmaceuticals USD 18M 1000K Sep/2025
Kangmei Pharma CNY 1.82M 150K Sep/2025
Karyopharm Therapeutics USD 11.38M 2.43M Sep/2024
Knight Therapeutics CAD 2.37M 6K Sep/2025
Laboratorios Farma EUR 699K 666.2K Jun/2025
MacroGenics USD 3.34M 2.54M Sep/2025
Medical Developments International AUD 18K 3K Jun/2025
Neuren Pharmaceuticals AUD 0 0 Jun/2024
Ovoca Bio EUR 7K 6K Jun/2022
Pfizer USD 711M 59M Dec/2025
Pharma Mar EUR 117K 1.24M Sep/2025
Qiagen NV USD 10.14M 1.92M Dec/2025
Roche Holding CHF 304M 7.5M Jun/2025
Sangamo BioSciences 97.56M 11.39M Jun/2025
Sanofi EUR -25M 252M Dec/2025
Sarepta Therapeutics USD 7.56M 2.33M Sep/2025
Sartorius EUR 49.5M 8.1M Sep/2025
Sino Biopharmaceutical CNY 76.87M 114.23M Jun/2024
Takeda JPY 123.63B 40.49B Dec/2025
Tilray USD 6.7M 2.73M Jun/2025
Zz Pientze Pharmaceu CNY 46.05M 36.5M Jun/2025